Literature DB >> 31729156

Okur-Chung neurodevelopmental syndrome in a patient from Spain.

Antonio F Martinez-Monseny1, Dídac Casas-Alba2, César Arjona1, Mercè Bolasell1, Paula Casano3, Jordi Muchart4, Federico Ramos2, Loreto Martorell1,5, Francesc Palau1,5,6,7, Alfredo García-Alix1,5,6,7, Mercedes Serrano2,5.   

Abstract

Okur-Chung neurodevelopmental syndrome (OCNS, MIM#617062) is a rare autosomal dominant syndrome related to CSNK2A1 mutations. It is characterized by intellectual disability, hypotonia, feeding and speech difficulties, dysmorphic features, and multisystem involvement. To date, less than 30 patients with OCNS have been described in detail in the literature, primarily in Asian populations. Here, we report a 5-year-old Spanish female with OCNS arising from a novel CSNK2A1 mutation c.149A>G, p.Tyr50Cys. Although her clinical features were compatible with OCNS syndrome, magnetic resonance imaging unexpectedly showed a duplication of the pituitary gland, a clinical finding not previously related to any known genetic condition. Other novel signs were an absence of the olfactory bulbs and multiple duplications of cervical vertebrae. We suggest that the midline abnormalities may be a significant part of this condition and lead to diagnostic suspicion. However, further descriptions are needed.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990CSNK2A1; Okur-Chung neurodevelopmental syndrome; pituitary gland duplication

Mesh:

Substances:

Year:  2019        PMID: 31729156     DOI: 10.1002/ajmg.a.61405

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

1.  Okur-Chung neurodevelopmental syndrome-linked CK2α variants have reduced kinase activity.

Authors:  I Dominguez; J M Cruz-Gamero; V Corasolla; N Dacher; S Rangasamy; A Urbani; V Narayanan; H Rebholz
Journal:  Hum Genet       Date:  2021-05-04       Impact factor: 4.132

2.  Persistent Hyperplastic Primary Vitreous with Microphthalmia and Coloboma in a Patient with Okur-Chung Neurodevelopmental Syndrome.

Authors:  Hiroaki Murakami; Tomoko Uehara; Yumi Enomoto; Naoto Nishimura; Tatsuro Kumaki; Yukiko Kuroda; Mizuki Asano; Noriko Aida; Kenjiro Kosaki; Kenji Kurosawa
Journal:  Mol Syndromol       Date:  2021-09-22

Review 3.  Comparing Two Neurodevelopmental Disorders Linked to CK2: Okur-Chung Neurodevelopmental Syndrome and Poirier-Bienvenu Neurodevelopmental Syndrome-Two Sides of the Same Coin?

Authors:  Demetra Ballardin; Jose M Cruz-Gamero; Thierry Bienvenu; Heike Rebholz
Journal:  Front Mol Biosci       Date:  2022-05-26

Review 4.  Protein kinase CK2: a potential therapeutic target for diverse human diseases.

Authors:  Christian Borgo; Claudio D'Amore; Stefania Sarno; Mauro Salvi; Maria Ruzzene
Journal:  Signal Transduct Target Ther       Date:  2021-05-17

5.  Identification of novel CSNK2A1 variants and the genotype-phenotype relationship in patients with Okur-Chung neurodevelopmental syndrome: a case report and systematic literature review.

Authors:  Ruo-Hao Wu; Wen-Ting Tang; Kun-Yin Qiu; Xiao-Juan Li; Dan-Xia Tang; Zhe Meng; Zhan-Wen He
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.